Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in NMRA — Neumora Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in NMRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$635,823
-$1,782,646 QoQ
Shares Held
374,014
-69.8% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 111 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NMRA Over Time

Shares Held

Position Value (USD)

Derivatives in NMRA

reported options exposure · as of Jun 30, 2026
CallValue
$152,150
CallShares
89,500
PutValue
$564,910
PutShares
332,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names. NMRA ranks #151 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NMRA

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $152,150 89,500
2026-06-30 $635,823 374,014
2026-06-30 $564,910 332,300
2026-03-31 $2,418,469 1,240,241
2026-03-31 $311,025 159,500
2026-03-31 $244,920 125,600
2025-12-31 $1,321,506 738,272
2025-12-31 $109,369 61,100
2025-09-30 $66,430 36,500
2025-09-30 $27,482 15,100
2025-09-30 $772,124 424,244
2025-06-30 $198,478 270,776
2025-06-30 $9,015 12,300
2025-03-31 $27,800 27,800
2025-03-31 $182,341 182,341
2024-12-31 $384,578 36,281
2024-12-31 $8,414,280 793,800
2024-12-31 $4,640,680 437,800
2024-09-30 $136,063 10,300
2024-09-30 $576,642 43,652
2024-09-30 $487,449 36,900
2024-06-30 $449,231 45,700
2024-06-30 $523,447 53,250
2024-03-31 $294,250 21,400
2024-03-31 $156,626 11,391
2023-12-31 $242,110 14,200
2023-12-31 $193,125 11,327
2023-12-31 $206,305 12,100
2023-09-30 $406,847 28,834